DE3750984D1 - Verwendung von 1-(3'-trifluormethyl-4'-nitrophenyl)-4,4- dimethylimidazolin-2,5-dion zur herstellung eines medikaments zur behandlung von hormonabhängigen krebserkrankungen ausser denen der prostata, der haut und des grimmdarms. - Google Patents

Verwendung von 1-(3'-trifluormethyl-4'-nitrophenyl)-4,4- dimethylimidazolin-2,5-dion zur herstellung eines medikaments zur behandlung von hormonabhängigen krebserkrankungen ausser denen der prostata, der haut und des grimmdarms.

Info

Publication number
DE3750984D1
DE3750984D1 DE3750984T DE3750984T DE3750984D1 DE 3750984 D1 DE3750984 D1 DE 3750984D1 DE 3750984 T DE3750984 T DE 3750984T DE 3750984 T DE3750984 T DE 3750984T DE 3750984 D1 DE3750984 D1 DE 3750984D1
Authority
DE
Germany
Prior art keywords
prostate
dione
nitrophenyl
dimethylimidazoline
trifluormethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3750984T
Other languages
English (en)
Other versions
DE3750984T2 (de
Inventor
Martine Moguilewsky
Marie-Madeleine Bouton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of DE3750984D1 publication Critical patent/DE3750984D1/de
Publication of DE3750984T2 publication Critical patent/DE3750984T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3750984T 1986-11-04 1987-11-03 Verwendung von 1-(3'-trifluormethyl-4'-nitrophenyl)-4,4- dimethylimidazolin-2,5-dion zur herstellung eines medikaments zur behandlung von hormonabhängigen krebserkrankungen ausser denen der prostata, der haut und des grimmdarms. Expired - Lifetime DE3750984T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8648618A IT1214735B (it) 1986-11-04 1986-11-04 Impiego di 1-(3'-trifluorometil 4'nitrofenil) 4,4-dimetilimidazolin2,5-dione per il trattamento di cancri ormonodipendenti diverso da quello della prostata
PCT/FR1987/000435 WO1988003404A1 (fr) 1986-11-04 1987-11-03 Application de la 1-(3'trifluoromethyl 4'-nitrophenyl) 4,4-dimethyl imidazoline 2,5-dione au traitement des cancers hormonodependants autres que celui de la prostate

Publications (2)

Publication Number Publication Date
DE3750984D1 true DE3750984D1 (de) 1995-02-23
DE3750984T2 DE3750984T2 (de) 1995-05-18

Family

ID=11267665

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3750984T Expired - Lifetime DE3750984T2 (de) 1986-11-04 1987-11-03 Verwendung von 1-(3'-trifluormethyl-4'-nitrophenyl)-4,4- dimethylimidazolin-2,5-dion zur herstellung eines medikaments zur behandlung von hormonabhängigen krebserkrankungen ausser denen der prostata, der haut und des grimmdarms.

Country Status (6)

Country Link
EP (1) EP0301034B1 (de)
JP (1) JP2777888B2 (de)
AT (1) ATE116852T1 (de)
DE (1) DE3750984T2 (de)
IT (1) IT1214735B (de)
WO (1) WO1988003404A1 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2329276A1 (fr) * 1975-10-29 1977-05-27 Roussel Uclaf Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant
FR2465486A1 (fr) * 1979-09-21 1981-03-27 Roussel Uclaf Nouvelle application utilisant la lh-rh ou des agonistes

Also Published As

Publication number Publication date
JP2777888B2 (ja) 1998-07-23
ATE116852T1 (de) 1995-01-15
IT8648618A0 (it) 1986-11-04
JPH01501230A (ja) 1989-04-27
EP0301034A1 (de) 1989-02-01
IT1214735B (it) 1990-01-18
WO1988003404A1 (fr) 1988-05-19
DE3750984T2 (de) 1995-05-18
EP0301034B1 (de) 1995-01-11

Similar Documents

Publication Publication Date Title
GEP20032897B (en) Epothilone Derivatives
NL300140I2 (nl) Galanthamine, of verbindingen die eraan analoog zijn, voor behandeling van de ziekte van Alzheimer.
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
IL125282A (en) Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases
GEP20012500B (en) Inhibitors of Protein Farnesyl Transferase
MY121548A (en) Compounds and methods for the treatment of cancer
DE69735367D1 (de) THERAPEUTISCHE MULTISPEZIFISCHE VERBINDUNGEN, DIE ANTIKÖRPER GEGEN DEN FCalpha-REZEPTOR ENTHALTEN
NO931635D0 (no) Fremgangsmaate for fremstilling av kinazolin-derivater
ES2160707T3 (es) Composiciones que comprenden agentes deteriorantes del adn y p53.
NO20075065L (no) Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
ATE94387T1 (de) Verwendung von n-myristoyl-(s)-phenylalanin zur herstellung eines medikaments zur behandlung von krankheiten mittels hemmung der myristoylierung.
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
DE69202441D1 (de) Melatoninderivate und Kombinationen mit Antiestrogenen zur Behandlung von Brustkarzinoma.
NO975662L (no) Anvendelse av 1,2,4-triazolderivater for fremstilling av et medikament for behandling av cancer
DE3780940D1 (de) Verwendung von ketonderivaten zur behandlung von depressionen.
IT1247509B (it) Composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus
ES2179204T3 (es) Hidrazinas 2-aminocarbonil-1,2-bis(metilsulfonil)-1-sustituidas antitumorales.
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
ATA901396A (de) Verwendung von melatonin zur behandlung von an medikamentensucht leidenden patienten
DE3750984D1 (de) Verwendung von 1-(3'-trifluormethyl-4'-nitrophenyl)-4,4- dimethylimidazolin-2,5-dion zur herstellung eines medikaments zur behandlung von hormonabhängigen krebserkrankungen ausser denen der prostata, der haut und des grimmdarms.
DE69327074D1 (de) Substituierte 1,2,4-Triazine-3,5-Dion Derivate und diese enthaltende Arzneimittel, insbesondere zur Behandlung von Coccidiose
DE69300127D1 (de) Verwendung von Azol-Derivaten zur Herstellung von Arzneimitteln zur Inhibierung der Aromatase und zur Behandlung Östrogen-abhängiger Krankheiten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: HOECHST MARION ROUSSEL, PUTEAUX, FR

8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS PHARMA S.A., ANTONY CEDEX, FR

8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN